ApprovalTrail

Approval · Notice of Compliance 28833 · 2022

CONRAY 60: Notice of Compliance 28833

Issued August 24, 2022

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
28833
Date
August 24, 2022
Company
Liebel-Flarsheim Company LlcRaleigh, North Carolina, United States
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Labelling Only
Reason
Administrative: Change in Product Ownership Removal of CONRAY 30 and CONRAY 43 from the Product Monograph (PM) and to update the PM to the 2020 Master Template

Products in this notice

BrandDINStatus today
CONRAY 6000131237Cancelled Post Market

Medicinal ingredients